Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic Efficacy of Naproxen Combinations in TMD
NCT04066426Phase 4Completed
- Sponsor
- Van Yuzuncu Yil University
- Start
- Mar 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Aprol in temporomandibular joint disorders (TMD) (4 arms), sponsored by Van Yuzuncu Yil University. Primary endpoint: Pain Evaluation at 1 month. Started Mar 2018; status: completed.
02
Drugs
Aprol
03
Conditions
temporomandibular joint disorders (TMD)
Beyond the preview
Go deeper on NCT04066426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04066426.